GPIA SEES "BUNDLING" OF GENERIC DRUG APPROVALS AS RESTRAINT TO COMPETITION; FDA GENERIC "BLOCKBUSTER" AND MONOGRAPH PROPOSALS RECEIVE LITTLE SUPPORT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".